Macleod Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Macleod Pharmaceuticals, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. Currently, 1 trademark is registered. Notable registered marks include UNIPRIM. The owner is based in Fort Collins, CO.

2600 Canton Court

Suite C

Fort Collins, CO 80525

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UNIBUTE
UNIBUTE
Cancelled 2003
UNIXIN
UNIXIN
Cancelled 2003
MACLEOD
MACLEOD
Cancelled 1993
TRI-SPAN
TRI-SPAN
Abandoned 1993
NESTAKET
NESTAKET
Abandoned 1992
M
M
Cancelled 1991
UNIJECT
UNIJECT
Abandoned 1991
UNICIL
UNICIL
Abandoned 1991
UNIPRIM
UNIPRIM
Registered 1990

Trademark Classifications

Macleod Pharmaceuticals, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Macleod Pharmaceuticals, Inc. have?

Macleod Pharmaceuticals, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 4 cancelled.

What trademark classes does Macleod Pharmaceuticals, Inc. file in?

Macleod Pharmaceuticals, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Macleod Pharmaceuticals, Inc.'s most well-known trademarks?

Macleod Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as UNIPRIM. These are among 1 currently registered trademark in the portfolio.

What is Macleod Pharmaceuticals, Inc.'s trademark registration success rate?

Macleod Pharmaceuticals, Inc. has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.